tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
VVOS
Vivos Therapeutics
RESEARCH TOOLSreports

Vivos Therapeutics (VVOS) Financial Statements

Compare
227 Followers

Vivos Therapeutics Financial Overview

Vivos Therapeutics's market cap is currently $12.46M. The company's EPS TTM is $; its P/E ratio is -1.57; Vivos Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Dec 23Dec 22Mar 22Dec 20
Income Statement
Total Revenue$ 15.03M$ 13.80M$ 16.02M$ 16.89M$ 13.07M
Gross Profit$ 9.02M$ 8.27M$ 10.02M$ 12.60M$ 10.41M
Operating Income$ -11.17M$ -17.30M$ -25.03M$ -19.47M$ -8.71M
EBITDA$ -10.55M$ -16.68M$ -24.36M$ -19.54M$ -11.24M
Net Income$ -11.14M$ -13.58M$ -23.84M$ -20.29M$ -12.06M
Balance Sheet
Cash & Short-Term Investments$ 6.26M$ 1.64M$ 3.52M$ 24.03M$ 18.21M
Total Assets$ 15.28M$ 10.73M$ 13.72M$ 33.69M$ 25.33M
Total Debt$ 1.51M$ 2.00M$ 2.41M$ 1.63M$ 1.29M
Net Debt$ -4.75M$ 352.00K$ -1.11M$ -22.40M$ -16.92M
Total Liabilities$ 7.33M$ 10.32M$ 8.92M$ 8.15M$ 8.41M
Stockholders' Equity$ 7.95M$ 411.00K$ 4.80M$ 25.54M$ 16.92M
Cash Flow
Free Cash Flow$ -13.26M$ -12.75M$ -20.51M$ -18.13M$ -5.80M
Operating Cash Flow$ -12.69M$ -11.95M$ -19.59M$ -15.73M$ -5.68M
Investing Cash Flow$ -568.00K$ -853.00K$ -924.00K$ -2.61M$ -120.25K
Financing Cash Flow$ 17.88M$ 10.92M$ 0.00$ 24.17M$ 23.54M
Currency in USD

Vivos Therapeutics Earnings and Revenue History

Income Statement >

Vivos Therapeutics Debt to Assets

Balance Sheet >

Vivos Therapeutics Cash Flow

Cash Flow >

Vivos Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >